Morphic to Present at SVB Leerink Global Healthcare Conference

Rhea-AI Summary

Morphic Therapeutic (Nasdaq: MORF), a biotechnology company focused on oral integrin therapies, will participate in the virtual SVB Leerink Global Healthcare conference on February 16, 2023. The event will feature a fireside chat scheduled for 8:40 AM ET. A live webcast will be available on the Investor section of Morphic's website, with an archived replay accessible following the conference. Morphic is developing treatments for serious chronic diseases such as autoimmune, cardiovascular, and metabolic diseases, leveraging its innovative MInT technology platform in collaboration with Janssen.

WALTHAM, Mass., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that its management team will participate in the virtual SVB Leerink Global Healthcare conference including a hosted fireside chat.

Presentation Information

8:40 AM ET, Thursday February 16, 2023

Fireside Chat at the SVB Leerink Conference

A live webcast of the presentation will be available on the Investor section of Morphic’s website at www.morphictx.com. An archived replay will be available on the company’s website following the conference.

About Morphic Therapeutic
Morphic Therapeutic is a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer. Morphic is also advancing its pipeline and discovery activities in collaborations with Janssen using its proprietary MInT technology platform which leverages the Company’s unique understanding of integrin structure and biology. For more information, visit www.morphictx.com.

Contacts
Morphic Therapeutic
Chris Erdman
chris.erdman@morphictx.com
617.686.1718

FAQ

When is Morphic Therapeutic's participation in the SVB Leerink conference?

Morphic Therapeutic will participate in the SVB Leerink Global Healthcare conference on February 16, 2023, at 8:40 AM ET.

Where can I watch the Morphic Therapeutic presentation?

The presentation by Morphic Therapeutic will be available for live streaming on the Investor section of their website.

What is Morphic Therapeutic's focus in biotechnology?

Morphic Therapeutic specializes in developing oral integrin therapies for serious chronic diseases, including autoimmune and cardiovascular diseases.

What technology platform does Morphic Therapeutic use?

Morphic Therapeutic uses its proprietary MInT technology platform to enhance its understanding of integrin structure and biology.